Kenmare Capital Partners Boosted Its Facebook (FB) Position; Wright Medical Group N.V (WMGI) Shorts Decreased By 6.06% 
November 11, 2017 - By Migdalia James 
Kenmare Capital Partners Llc increased Facebook Inc (FB) stake by 22.6% reported in 2017Q2 SEC filing. Kenmare Capital Partners Llc acquired 8,047 shares as Facebook Inc (FB)’s stock rose 10.88%. The Kenmare Capital Partners Llc holds 43,653 shares with $6.59M value, up from 35,606 last quarter. Facebook Inc now has $516.14B valuation. The stock decreased 0.47% or $0.84 on November 10, reaching $178.46. About 11.07M shares traded. Facebook Inc (NASDAQ:FB) has risen 26.75% since November 11, 2016 and is uptrending. It has outperformed by 10.05% the S&P500. 
Wright Medical Group N.V (NASDAQ:WMGI) had a decrease of 6.06% in short interest. WMGI’s SI was 8.87M shares in November as released by FINRA. Its down 6.06% from 9.44 million shares previously. With 1.15 million avg volume, 8 days are for Wright Medical Group N.V (NASDAQ:WMGI)’s short sellers to cover WMGI’s short positions. The SI to Wright Medical Group N.V’s float is 9.68%. The stock decreased 1.50% or $0.36 on November 10, reaching $23.72. About 723,868 shares traded. Wright Medical Group Inc (NASDAQ:WMGI) has risen 49.62% since November 11, 2016 and is uptrending. It has outperformed by 32.92% the S&P500. 
Among 18 analysts covering Wright Medical Group ( NASDAQ:WMGI ), 14 have Buy rating, 0 Sell and 4 Hold. Therefore 78% are positive. Wright Medical Group had 33 analyst reports since August 20, 2015 according to SRatingsIntel. RBC Capital Markets maintained the shares of WMGI in report on Friday, September 1 with “Buy” rating. On Wednesday, November 4 the stock rating was initiated by Sterne Agee CRT with “Buy”. The stock of Wright Medical Group Inc (NASDAQ:WMGI) has “Hold” rating given on Thursday, August 3 by Oppenheimer. The firm earned “Hold” rating on Thursday, August 20 by Needham. Jefferies maintained the stock with “Buy” rating in Tuesday, October 10 report. JP Morgan upgraded Wright Medical Group Inc (NASDAQ:WMGI) on Wednesday, July 13 to “Overweight” rating. RBC Capital Markets maintained Wright Medical Group Inc (NASDAQ:WMGI) rating on Monday, October 2. RBC Capital Markets has “Buy” rating and $31.0 target. The rating was maintained by BMO Capital Markets with “Outperform” on Thursday, November 2. The rating was upgraded by Jefferies to “Buy” on Monday, November 30. Bank of America downgraded the stock to “Neutral” rating in Tuesday, April 11 report. 
Wright Medical Group, Inc. is a global specialty orthopaedic company. The company has market cap of $1.22 billion. The Firm through Wright Medical Technology, Inc. and other subsidiaries provides extremity and biologic solutions that enable clinicians to alleviate pain and restore the patients’ lifestyles. It currently has negative earnings. The Firm operates through three divisions: U.S., International and BioMimetic. 
Since May 11, 2017, it had 0 insider purchases, and 16 selling transactions for $190.39 million activity. Sandberg Sheryl sold $24.51 million worth of stock. Shares for $5.71M were sold by Schroepfer Michael Todd. Zuckerberg Mark sold 138,149 shares worth $21.25M. Another trade for 594,246 shares valued at $88.97M was made by Koum Jan on Monday, May 15. $115,308 worth of Facebook Inc (NASDAQ:FB) was sold by Stretch Colin. On Wednesday, June 7 Cox Christopher K sold $2.45M worth of Facebook Inc (NASDAQ:FB) or 16,000 shares. $2.30M worth of Facebook Inc (NASDAQ:FB) was sold by Wehner David M.. 
Among 53 analysts covering Facebook ( NASDAQ:FB ), 49 have Buy rating, 2 Sell and 2 Hold. Therefore 92% are positive. Facebook had 207 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Wednesday, July 26 by Stifel Nicolaus. RBC Capital Markets maintained Facebook Inc (NASDAQ:FB) on Thursday, January 28 with “Outperform” rating. The firm has “Outperform” rating given on Thursday, November 5 by Credit Suisse. Cantor Fitzgerald maintained Facebook Inc (NASDAQ:FB) on Thursday, August 27 with “Buy” rating. The firm has “Overweight” rating by KeyBanc Capital Markets given on Thursday, November 2. The rating was maintained by Brean Capital on Thursday, July 30 with “Buy”. The rating was maintained by Deutsche Bank on Thursday, November 5 with “Buy”. The rating was maintained by Citigroup with “Buy” on Monday, September 19. The rating was maintained by UBS on Thursday, April 28 with “Buy”. The stock has “Buy” rating by Canaccord Genuity on Thursday, November 2. 
Investors sentiment increased to 1.4 in Q2 2017. Its up 0.05, from 1.35 in 2017Q1. It increased, as 48 investors sold FB shares while 553 reduced holdings. 159 funds opened positions while 684 raised stakes. 1.62 billion shares or 0.41% less from 1.63 billion shares in 2017Q1 were reported. Front Barnett Associate Limited Company has 0.06% invested in Facebook Inc (NASDAQ:FB) for 2,207 shares. Curbstone Mngmt Corp accumulated 0.56% or 6,136 shares. Hemenway Tru Com Limited Com has invested 0.08% in Facebook Inc (NASDAQ:FB). Levin Strategies LP holds 0.03% of its portfolio in Facebook Inc (NASDAQ:FB) for 11,185 shares. Timessquare Cap Mngmt Limited Liability Com accumulated 58,605 shares. New England Mgmt Inc invested in 0.17% or 1,485 shares. Empirical Service Limited Liability Com owns 3,610 shares. Lenox Wealth stated it has 0.07% of its portfolio in Facebook Inc (NASDAQ:FB). Scholtz Co Ltd Liability Co accumulated 7,137 shares. Oxbow Advisors invested 0.41% in Facebook Inc (NASDAQ:FB). Montecito Natl Bank & Tru holds 7,327 shares. Beech Hill Advisors reported 55,170 shares. Moreover, Caprock Gp Inc has 0.63% invested in Facebook Inc (NASDAQ:FB). Legg Mason Asset Management (Japan) Ltd holds 13,500 shares or 1.67% of its portfolio. Etrade Mngmt Limited Liability Co owns 36,928 shares. Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter. Free Newsletter Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: Recent Posts